Evidence map›Paper›PMID 31261851›Full record

ReviewInternational journal of molecular sciences2019

Glucan and Mannan-Two Peas in a Pod.

Tatiana A Korolenko, Nataliya P Bgatova, Vaclav Vetvicka

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
7.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Spent Brewer's Yeast Lysis Enables aInternational journal of molecular sciences · 2024
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Immunostimulatory Effect of Postbiotics Prepared fromPharmaceuticals (Basel, Switzerland) · 2022
    Article
  12. Characterization and Antioxidant Activity of Mannans fromMolecules (Basel, Switzerland) · 2022
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Tatiana A KorolenkoDepartment of Experimental Models of Neurodegeneration, Scientific Research Institute of Physiology and Basic Medicine, Timakov St. 4, 630117 Novosibirsk, Russia.
Nataliya P BgatovaLaboratory of Electron Miscroscopy, Research Institute of Clinical and Experimental Lymphology-Affiliated Branch of Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, 630060 Novosibirsk, Russia.ORCID 0000-0002-4507-093X
Vaclav VetvickaDepartment of Pathology, University of Louisville, 511 S. Floyd, Louisville, KY 40292, USA. vaclav.vetvicka@louisville.edu.ORCID 0000-0002-3227-2938
Institute of Physiology and Basic Medicine · RURussian Academy of Sciences · RUUniversity of Louisville · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent decades, various polysaccharides isolated from algae, mushrooms, yeast, and higher plants have attracted serious attention in the area of nutrition and medicine. The reasons include their low toxicity, rare negative side effects, relatively low price, and broad spectrum of therapeutic actions. The two most and best-studied polysaccharides are mannan and glucan. This review focused on their biological properties.

Indexed as

AnimalsAntineoplastic AgentsFungal PolysaccharidesGlucansHumansHypolipidemic AgentsImmunologic FactorsMacrophagesMannansAntineoplastic AgentsFungal PolysaccharidesGlucansHypolipidemic AgentsImmunologic FactorsMannansglucanglucomannanimmunomodulatormannanpolysaccharidetherapeutic

Identifiers

PMID31261851
PMCPMC6651133
OpenAlexW2956037650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.